Related Experiment Video
Updated: Sep 29, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Antithrombotic prescribing in atrial fibrillation: application of a prescribing indicator and multidisciplinary
Rohan A Elliott1, Michael C Woodward, C Alice Oborne
1Centre for Applied Gerontology, Bundoora Extended Care Centre, Bundoora VIC 3083, Australia. rohan.elliott@armc.org.au
Insights
Antithrombotic therapy for atrial fibrillation in older patients was under-prescribed. Audit and feedback improved prescribing, particularly aspirin, though warfarin remained under-used.
Area of Science:
- Geriatric Medicine
- Cardiology
- Pharmacology
Background:
- Atrial fibrillation is prevalent in elderly populations, increasing ischemic stroke risk.
- Antithrombotic therapy is underutilized despite its proven efficacy in stroke prevention.
Purpose of the Study:
- To audit antithrombotic prescribing in elderly inpatients with atrial fibrillation using an evidence-based indicator.
- To evaluate the impact of multidisciplinary feedback on antithrombotic prescribing rates.
Main Methods:
- Cross-sectional notes-based audits were conducted before and after feedback.
- Data collected from 1416 inpatients aged 65+ across nine Australian hospitals.
- Appropriateness defined as receiving warfarin/aspirin or having contraindications.
Main Results:
- Appropriate antithrombotic prescribing increased significantly from 72% to 92% post-feedback (P<0.0001).
- Aspirin prescribing saw the most substantial improvement; warfarin remained under-prescribed.
- Prescribing appropriateness slightly decreased at 6 months but remained elevated.
Conclusions:
- Older patients with atrial fibrillation are frequently under-prescribed antithrombotics.
- Audit and multidisciplinary feedback effectively improved antithrombotic use.
- The intervention demonstrated a greater impact on aspirin compared to warfarin prescribing.
Background:
Atrial fibrillation is common in older people, and is associated with an increased risk of ischaemic stroke. Antithrombotic therapy reduces stroke-risk, but is known to be under-prescribed.
Objectives:
To use an evidence-based indicator to audit antithrombotic prescribing for older hospital inpatients with atrial fibrillation, and to assess whether feedback of audit results to hospital staff increases antithrombotic use.
Design:
Cross-sectional notes-based audits, before and after feedback.
Setting:
Six Aged Care and three General Medicine units at nine Australian public teaching hospitals between September 1998 and May 1999.
Subjects:
1416 hospital inpatients aged 65 years and over (median age 81).
Methods:
Medication charts were reviewed to identify patients prescribed digoxin or amiodarone. Presence of atrial fibrillation was confirmed by review of the patients' medical notes. To be considered appropriate, patients with atrial fibrillation had to be receiving either warfarin or aspirin (or both), or have documented contraindications to both agents. Feedback of audit results was provided to medical, pharmacy and nursing staff at multidisciplinary meetings. Changes in antithrombotic prescribing 4-8 weeks and 6 months after feedback were assessed. Prescribing 8 weeks prior to feedback was assessed retrospectively.
Results:
Appropriateness of the decision to prescribe (or not prescribe) antithrombotic therapy increased from 81/112 (72%) immediately prior to feedback to 97/105 (92%) 4-8 weeks later (P<0.0001). Six months after feedback, appropriateness of prescribing declined slightly, to 85% (p=0.36). Over the 8 weeks prior to feedback, appropriateness of prescribing did not change (74% versus 77%, p=0.80). Increased aspirin prescribing accounted for most of the improvement in antithrombotic use after feedback, while warfarin continued to be under-used.
Conclusions:
Antithrombotics were under-prescribed for older patients with atrial fibrillation. Audit and multidisciplinary feedback resulted in increased antithrombotic prescribing. The intervention had a greater impact on aspirin prescribing compared with warfarin.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Acute Coronary Syndrome IV: Interprofessional Care
Atherosclerosis III: Management
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
